Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Genes and Cancer is Scopus-indexed (Q1, CiteScore 7.3). Published by Impact Journals LLC.
Checked against the index lists dated .
ISSN 1947-6019Verify ISSN ↗1947-6027Verify ISSN ↗
Publisher: Impact Journals LLC
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics | 81 / 357 | 77th | Q1 |
| Cancer Research | 72 / 233 | 69th | Q2 |
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q1, CiteScore 7.3.
Genes and Cancer is Q1 in Genetics (rank 81 of 357) and Q2 in Cancer Research (rank 72 of 233), by CiteScore 2025.
Genes and Cancer is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 7.3, quartile Q1, 77th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.517, quartile Q1, with an H-index of 88.
Genes and Cancer is published by Impact Journals LLC. Its print ISSN is 1947-6019 and its online ISSN is 1947-6027.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
No — it is not registered as an open-access journal in DOAJ or Scopus.
Genes and Cancer has an h-index of 97 and a 2-year mean of 1.25 citations per paper (OpenAlex). Its Scopus CiteScore is 7.3, quartile Q1. On 2-year citations it ranks #279 of 353 Scopus journals in Genetics.
Genes and Cancer published 6 papers in 2025; its busiest recent year was 2017 with 47. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 32 research articles (2021–2026), authors are most often from United States (50%), Iran (15.6%) and Canada (6.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.